Publications 2026

Dreyling M, Doorduijn J, Giné E, Jerkeman M, Walewski J, Hutchings M, Mey U, Riise J, Trneny M, Vergote VKJ, Shpilberg O, da Silva MG, Leppä S, Jiang L, Stilgenbauer S, Kerkhoff A, Jachimowicz RD, Heß G, Meerten TV, Wirths S, Herhaus P, Novak U, Dierlamm J, Hänel M, Hanoun C et al. (2026)
Addition of autologous stem-cell transplantation to an ibrutinib-containing first-line treatment in patients aged 18-65 years with mantle cell lymphoma (TRIANGLE): 4·5-year follow-up of a three-arm, randomised, open-label, phase 3 superiority trial of the European MCL Network
Lancet, 407 (10542), 1953-1967
DOI 10.1016/S0140-6736(26)00362-4, PubMed 42134356

König M, Holmøy T, Nygaard GO, Riise J, Midtvedt K, Goll GL, Jørgensen KK, Munthe LA, Fevang B, Myhre AE, Trøseid M (2026)
Vaccination of immunosuppressed patients
Tidsskr Nor Laegeforen, 146 (5)
DOI 10.4045/tidsskr.25.0555, PubMed 42012114

Ladetto M, Gutmair K, Tavarozzi R, Pawlikowski A, Schomaker M, Doorduijn J, Giné E, Jerkeman M, Walewski J, Hutchings M, Mey U, Riise J, Trneny M, Vergote VKJ, Horowitz NA, Gomes da Silva M, Leppä S, Jiang L, Stilgenbauer S, Kerkhoff A, Jachimowicz RD, Heß G, van Meerten T, Wirths S, Herhaus P et al. (2026)
Rituximab Maintenance Added to Ibrutinib-Containing Therapy in Younger, Untreated Patients With Mantle Cell Lymphoma: Results From the TRIANGLE Trial
J Clin Oncol, JCO2600705 (in press)
DOI 10.1200/JCO-26-00705, PubMed 42447409

Publications 2025

Forsgren E, Jørgensen RRK, Bentzen H, Riise J, Haaber J, Pasanen A, Kuitunen H, Wader KF, El-Galaly TC, Hutchings M, Glimelius I, Jerkeman M (2025)
Ibrutinib, lenalidomide, and rituximab in relapsed mantle cell lymphoma: Long-term follow-up of the Nordic Lymphoma Group MCL6 Philemon trial
Hemasphere, 9 (3), e70101
DOI 10.1002/hem3.70101, PubMed 40104044

Jiang L, Ladetto M, Hermine O, Kluin-Nelemans JC, Walewski J, Doorduijn J, Vergote V, Giné E, Jerkeman M, Hutchings M, Trneny M, Mey U, Riise J, Shpilberg O, Da Silva MG, Ribrag V, Schmidt C, Klapper W, Unterhalt M, Dreyling M, Hoster E (2025)
Marked survival gains in patients ≤ 65 years with advanced-stage mantle cell lymphoma: a pooled analysis of six randomized phase III trials, 1996-2020
Haematologica, 111 (5), 1694-1704
DOI 10.3324/haematol.2025.288929, PubMed 41163573

Lewis DJ, Jerkeman M, Sorrell L, Wright D, Glimelius I, Poulsen CB, Pasanen A, Rawstron A, Wader KF, Morley N, Burton C, Davies AJ, Lagerlöf I, Dalal S, De Tute R, McNamara C, Crosbie N, Toldbod HE, Sanders J, Allgar V, Aroori S, Warner M, Scully C, Wainman B, Christensen JH et al. (2025)
Ibrutinib and rituximab versus immunochemotherapy in patients with previously untreated mantle cell lymphoma (ENRICH): a randomised, open-label, phase 2/3 superiority trial
Lancet, 406 (10514), 1953-1968
DOI 10.1016/S0140-6736(25)01432-1, PubMed 41052510

Meriranta L, Rask Kragh Jørgensen R, Pasanen A, Kolstad A, Hutchings M, Niemann CU, El-Galaly TC, Riise J, Christensen JH, Sonnevi K, Pedersen LB, Wader KF, Glimelius I, Leppä S, Jerkeman M (2025)
Circulating tumor DNA determinants of response and outcome in relapsed/refractory mantle cell lymphoma
Blood Adv, 9 (17), 4528-4541
DOI 10.1182/bloodadvances.2025015791, PubMed 40402132

Publications 2024

Dreyling M, Doorduijn J, Giné E, Jerkeman M, Walewski J, Hutchings M, Mey U, Riise J, Trneny M, Vergote V, Shpilberg O, Gomes da Silva M, Leppä S, Jiang L, Stilgenbauer S, Kerkhoff A, Jachimowicz RD, Celli M, Hess G, Arcaini L, Visco C, van Meerten T, Wirths S, Zinzani PL, Novak U et al. (2024)
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network
Lancet, 403 (10441), 2293-2306
DOI 10.1016/S0140-6736(24)00184-3, PubMed 38705160

Jerkeman M, Kolstad A, Hutchings M, Pasanen A, Meriranta L, Niemann CU, Kragh Jørgensen RR, El-Galaly TC, Riise J, Leppä S, Christensen JH, Sonnevi K, Pedersen LB, Wader KF, Glimelius I (2024)
MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial
Blood Adv, 8 (2), 407-415
DOI 10.1182/bloodadvances.2023011920, PubMed 38113470

Publications 2023

Vistnes M, Erusappan PM, Sasi A, Nordén ES, Bergo KK, Romaine A, Lunde IG, Zhang L, Olsen MB, Øgaard J, Carlson CR, Wang CH, Riise J, Dahl CP, Fiane AE, Hauge-Iversen IM, Espe E, Melleby AO, Tønnessen T, Aronsen JM, Sjaastad I, Christensen G (2023)
Inhibition of the extracellular enzyme A disintegrin and metalloprotease with thrombospondin motif 4 prevents cardiac fibrosis and dysfunction
Cardiovasc Res, 119 (10), 1915-1927
DOI 10.1093/cvr/cvad078, PubMed 37216909

Publications 2022

Riise J, Meyer S, Blaas I, Chopra A, Tran TT, Delic-Sarac M, Hestdalen ML, Brodin E, Rustad EH, Dai KZ, Vaage JT, Nissen-Meyer LSH, Sund F, Wader KF, Bjornevik AT, Meyer PA, Nygaard GO, König M, Smeland S, Lund-Johansen F, Olweus J, Kolstad A (2022)
Rituximab-treated patients with lymphoma develop strong CD8 T-cell responses following COVID-19 vaccination
Br J Haematol, 197 (6), 697-708
DOI 10.1111/bjh.18149, PubMed 35254660

Publications 2013

Bach T, Bergholtz S, Riise J, Qvigstad E, Skomedal T, Osnes JB, Levy FO (2013)
Identification of small molecule NPR-B antagonists by high throughput screening--potential use in heart failure
Naunyn Schmiedebergs Arch Pharmacol, 387 (1), 5-14
DOI 10.1007/s00210-013-0940-6, PubMed 24297249

Publications 2012

Riise J, Nguyen CH, Hussain RI, Dahl CP, Ege MS, Osnes JB, Skomedal T, Sandnes DL, Levy FO, Krobert KA (2012)
Prostanoid-mediated inotropic responses are attenuated in failing human and rat ventricular myocardium
Eur J Pharmacol, 686 (1-3), 66-73
DOI 10.1016/j.ejphar.2012.04.022, PubMed 22546232

Riise J, Ørstavik Ø, Qvigstad E, Dahl CP, Osnes JB, Skomedal T, Levy FO, Krobert KA (2012)
Prostaglandin E1 facilitates inotropic effects of 5-HT4 serotonin receptors and β-adrenoceptors in failing human heart
Basic Res Cardiol, 107 (5), 295
DOI 10.1007/s00395-012-0295-z, PubMed 22923058

Publications 2008

Riise J, Nguyen CH, Qvigstad E, Sandnes DL, Osnes JB, Skomedal T, Levy FO, Krobert KA (2008)
Prostanoid F receptors elicit an inotropic effect in rat left ventricle by enhancing myosin light chain phosphorylation
Cardiovasc Res, 80 (3), 407-15
DOI 10.1093/cvr/cvn216, PubMed 18703533